Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
Oluwatoyosi Adewunmi(The University of Texas MD Anderson Cancer Center), Jeffrey M. Rosen(Baylor College of Medicine)
Cited by 56
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
|Breast Cancer Research|2009|298
Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
|Journal of Mammary Gland Biology and Neoplasia|2010|243
Intratumoral Heterogeneity in a <i>Trp53</i> -Null Mouse Model of Human Breast Cancer
|Cancer Discovery|2015|73